↓ Skip to main content

ErbB2+ metastatic breast cancer treatment after progression on trastuzumab: a cost-effectiveness analysis for a developing country.

Overview of attention for article published in Revista de Salud Pública, May 2014
Altmetric Badge

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
95 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
ErbB2+ metastatic breast cancer treatment after progression on trastuzumab: a cost-effectiveness analysis for a developing country.
Published in
Revista de Salud Pública, May 2014
DOI 10.15446/rsap.v16n2.31690
Pubmed ID
Authors

Mario García Molina, Liliana Alejandra Chicaíza-Becerra, Liliana Alejandra Chicaíza-Becerra, Carlos Castañeda, Carlos Castañeda, Oscar Gamboa Garay, Oscar Gamboa Garay

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 95 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 95 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 20 21%
Student > Master 15 16%
Other 7 7%
Student > Bachelor 6 6%
Lecturer 6 6%
Other 16 17%
Unknown 25 26%
Readers by discipline Count As %
Medicine and Dentistry 27 28%
Pharmacology, Toxicology and Pharmaceutical Science 10 11%
Economics, Econometrics and Finance 10 11%
Social Sciences 4 4%
Nursing and Health Professions 2 2%
Other 8 8%
Unknown 34 36%